Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

117.06 -0.32 (-0.28%)
Streaming Delayed Price Updated: 12:40 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning! 
Via InvestorPlace
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TransMedics Group, Inc. on Behalf of TransMedics Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
From The Rosen Law Firm, P.A.
Via Business Wire
Earnings Preview: TransMedics Gr
 
Via Benzinga
Organ Transplant-Focused TransMedics Stock Soars, Solid Q3 Performance In Focus
TransMedics Group Inc (NASDAQ: TMDX) reported  
Via Benzinga
TransMedics Group Inc. (NASDAQ: TMDX) is a Leading Gainer in 11/7 Morning Trading
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak... 
Via Benzinga
Topics Stocks
2 No-Brainer Growth Stocks You Can Buy With Less Than $100 and Hold at Least 5 Years
The businesses underlying these stocks have a lot of growing to do. 
Via The Motley Fool
Exit Now! 3 Small-Cap Stocks to Sell in February 2024
Discover why these three small-cap stocks to sell in February 2024, as their risks overshadow potential rewards. 
Via InvestorPlace
Forget the "Magnificent Seven": These 2 Under-the-Radar Growth Stocks Are Better Bargains
Pick up some shares of these little-known growth stocks before they're swept up in the ongoing bull market. 
Via The Motley Fool
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
New Innovation-Themed Whitepaper to Debut at the February 1st Emerald Groundhog Day Investment Forum
From Emerald Asset Management PA, LLC
Via Business Wire
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more. 
Via InvestorPlace
Topics Artificial Intelligence
Investment Opportunities in the Innovation Economy Headline the 2024 Emerald Groundhog Day Investment Forum
From Emerald Asset Management PA, LLC
Via Business Wire
November Winners
The average stock in the large-cap Russell 1,000 rose 9.77% in November. There were 38 stocks in the index that gained more than 30%, 14 that gained more than 40%, and seven that gained more than 50%. 
Via Talk Markets
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money
These stocks just might have investors seeing double over the next few years. 
Via The Motley Fool
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
These innovators should have tremendous long-term growth prospects. 
Via The Motley Fool
Prediction: 3 Stocks That Could Trounce the Market
These stocks have what it takes to be huge winners over the next several years. 
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Most stocks aren't truly revolutionary. These really are. 
Via The Motley Fool
2 Top Growth Stocks to Buy Right Now and Hold for the Long Term
Not only are these two stocks projected to grow sales by 36% and 112% this year, they're poised to start generating profits in 2024. 
Via The Motley Fool
Food Trends Worth Chewing Over
Before you put your money into restaurants -- their stocks, not their menus -- you'll want to listen to this. 
Via The Motley Fool
3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates
Can these promising growth stocks continue rising in value? 
Via The Motley Fool
Topics Economy
2 Growth Stocks That Already Jumped 50% in November and Could Keep Climbing Higher
Recent gains could be the start of a longer bull run. 
Via The Motley Fool
Crude Oil Falls Sharply; Datadog Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500... 
Via Benzinga
Topics Stocks
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why Is TransMedics (TMDX) Stock Up 53% Today?
TransMedics stock is taking off on Tuesday as TMDX investors react to strong revenue and a guidance increase in its Q3 earnings report. 
Via InvestorPlace
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.